Browse diseases

…ethods A 31-year-old man who has sex with men (MSM) living with HIV on antiretroviral therapy with a prior history of treated syphi…

…ion To date, there is no proven licensed systemic treatment for neurofibromatosis type 2 (NF2)-related schwannomatosis patients. There is a need for mor…

…Background Hepatocellular carcinoma (HCC) patients are often diagnosed with advanced-stage disease.…

… with consistent healthcare-an opportunity to prevent and treat HIV that must not be overlooked, argues Pank Sethi.…

…While high-income countries successfully contained mpox outbreaks with minimal mortality, West Africa faces a severe in…

…and Methods Retrospective study of 286 virologically suppressed PWH with 378 documented blips identified from 9,157 viral load meas…

… tissue (GALT).Materials and Methods Sixty-seven virosuppressed PWH were enrolled, 32 continued 3-DR and 35 switched to 2-DR. Perip…

…while at T7 a more marked reduction was observed. Subjects with virological failure showed higher CAD and CAR levels, although differences were not…

…diction services should receive training to address problematic chemsex, also considering its increasing geographical spread.Abstract O…

…r women remain underrepresented in PrEP programs despite global HIV&AIDS statistics showing women accounting for 45% of all new infectio…

…ckground Long-acting cabotegravir (CAB-LA) is a key addition to HIV prevention but requires more resources than oral PrEP. To guide…

…Background While HIV-PrEP scale-up has expanded in several settings, key-populations at o…